WallStSmart

GE Vernova LLC (GEV)vsHarte Hanks Inc (HHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GE Vernova LLC generates 24576% more annual revenue ($39.38B vs $159.57M). GEV leads profitability with a 23.8% profit margin vs -0.5%. HHS appears more attractively valued with a PEG of 1.19. GEV earns a higher WallStSmart Score of 63/100 (C+).

GEV

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 7.0Value: 3.7Quality: 4.3
Piotroski: 4/9Altman Z: 1.02

HHS

Hold

37

out of 100

Grade: F

Growth: 2.0Profit: 2.5Value: 7.0Quality: 6.0
Piotroski: 5/9Altman Z: 13.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GEV.

HHSUndervalued (+70.7%)

Margin of Safety

+70.7%

Fair Value

$9.81

Current Price

$2.77

$7.04 discount

UndervaluedFair: $9.81Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEV6 strengths · Avg: 9.2/10
Market CapQuality
$308.81B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
75.7%10/10

Every $100 of equity generates 76 in profit

EPS GrowthGrowth
1816.0%10/10

Earnings expanding 1816.0% YoY

Profit MarginProfitability
23.8%9/10

Keeps 24 of every $100 in revenue as profit

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

Free Cash FlowQuality
$4.79B8/10

Generating 4.8B in free cash flow

HHS2 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
13.2210/10

Safe zone — low bankruptcy risk

Areas to Watch

GEV4 concerns · Avg: 2.5/10
P/E RatioValuation
33.5x4/10

Premium valuation, high expectations priced in

PEG RatioValuation
3.742/10

Expensive relative to growth rate

Price/BookValuation
20.5x2/10

Trading at 20.5x book value

Altman Z-ScoreHealth
1.022/10

Distress zone — elevated risk

HHS4 concerns · Avg: 2.5/10
Market CapQuality
$20.54M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.093/10

Elevated debt levels

Return on EquityProfitability
-3.8%2/10

ROE of -3.8% — below average capital efficiency

Revenue GrowthGrowth
-15.4%2/10

Revenue declined 15.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : GEV

The strongest argument for GEV centers on Market Cap, Return on Equity, EPS Growth. Profitability is solid with margins at 23.8% and operating margin at 5.5%. Revenue growth of 16.3% demonstrates continued momentum.

Bull Case : HHS

The strongest argument for HHS centers on Price/Book, Altman Z-Score. PEG of 1.19 suggests the stock is reasonably priced for its growth.

Bear Case : GEV

The primary concerns for GEV are P/E Ratio, PEG Ratio, Price/Book.

Bear Case : HHS

The primary concerns for HHS are Market Cap, Debt/Equity, Return on Equity.

Key Dynamics to Monitor

GEV profiles as a growth stock while HHS is a turnaround play — different risk/reward profiles.

GEV carries more volatility with a beta of 1.20 — expect wider price swings.

GEV is growing revenue faster at 16.3% — sustainability is the question.

GEV generates stronger free cash flow (4.8B), providing more financial flexibility.

Bottom Line

GEV scores higher overall (63/100 vs 37/100), backed by strong 23.8% margins and 16.3% revenue growth. HHS offers better value entry with a 70.7% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE Vernova LLC

INDUSTRIALS · SPECIALTY INDUSTRIAL MACHINERY · USA

GE Vernova LLC, an energy business company, generates electricity.

Visit Website →

Harte Hanks Inc

INDUSTRIALS · CONGLOMERATES · USA

Harte Hanks, Inc. is a customer experience company in the United States and internationally. The company is headquartered in Chelmsford, Massachusetts.

Visit Website →

Want to dig deeper into these stocks?